UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Burling Wealth Partners LLC

Burling Wealth Partners LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 67.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 3,082 shares of the healthcare conglomerate's stock after selling 6,287 shares during the period. Burling Wealth Partners LLC's holdings in UnitedHealth Group were worth $1,614,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in UNH. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the 4th quarter worth $30,000. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $41,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director directly owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have commented on the stock. Piper Sandler lowered their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. TD Securities reaffirmed a "hold" rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday. Finally, Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $414.35.

UnitedHealth Group Stock Performance

NYSE UNH traded down $4.46 during trading hours on Thursday, hitting $288.03. 14,738,720 shares of the stock were exchanged, compared to its average volume of 7,770,851. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The stock has a 50-day moving average of $308.39 and a 200 day moving average of $436.45. The company has a market cap of $261.28 billion, a price-to-earnings ratio of 12.06, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.07%. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.